Showing results (61-70 of 84) with videos related to

Sort By:
Pageof 9
International Journal of Cancer|August 24, 2000
Prognostic of DNA-synthesizing enzyme activities (thymidine kinase and thymidylate synthase) in 908 T1-T2, N0-N1, M0 breast cancers: a retrospective multicenter studyS Romain, F Spyratos, F Descotes, et al.
Cancer Research|May 15, 1987
Immunocytochemical study with monoclonal antibodies to progesterone receptor in human breast tumorsM Perrot-Applanat, M T Groyer-Picard, F Lorenzo, et al.
Lancet (London, England)|November 11, 1989
Cathepsin D: an independent prognostic factor for metastasis of breast cancerF Spyratos, T Maudelonde, J P Brouillet, et al.
Cancer Letters|November 2, 2001
ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinomaI Bièche, P Onody, F Lerebours, et al.
British Journal of Cancer|January 1, 1997
Comparison of a new microplate oestrogen receptor (ER) enzyme immunoassay with other ER detection methodsV Delage, S Deytieux, V Le Doussal, et al.
Bulletin Du Cancer|September 8, 1999
[Standardization and quality control in the evaluation of proliferation parameters in T1T2, N0N1, M0 breast cancer : multicentric retrospective study I. DNA synthesis enzyme activities]F Spyratos, S Romain, B Rostaing-Puissant, et al.
Bulletin Du Cancer|January 1, 1991
[Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk]P M Martin, S Romain, F Spyratos, et al.
Analytical Cellular Pathology : the Journal of the European Society for Analytical Cellular Pathology|February 1, 1994
Computer assisted image analysis of bladder tumour nuclei for morphonuclear and ploidy assessmentM C Colombel, M F Pous, C C Abbou, et al.
Journal of the National Cancer Institute|August 19, 1992
Multiparametric prognostic evaluation of biological factors in primary breast cancerF Spyratos, P M Martin, K Hacène, et al.
Bulletin Du Cancer|July 21, 2000
[Standards, Options and Recommendations (SOR) for endocrine therapy in patients with non metastatic breast cancer. FNCLCC]L Mauriac, M P Blanc-Vincent, E Luporsi, et al.
Pageof 9